灭活脊髓灰质炎病毒疫苗:消除脊髓灰质炎的必然选择
灭活脊髓灰质炎病毒疫苗(IPV)虽在20世纪60至70年代被口服脊髓灰质炎病毒疫苗(OPV)取代,但因持续使用OPV相关风险日益被认识,IPV已成为消除脊髓灰质炎的必然选择。基于灭活野生型脊髓灰质炎病毒的现代Salk IPV已在许多国家常规使用,通过循环抗体中和病毒对运动神经元的感染性来实现对麻痹的良好保护,并依既往暴露情况经黏膜抗体和免疫细胞提供不同程度的黏膜感染保护。IPV后接OPV的序贯免疫程序有潜力消除疫苗相关麻痹性脊髓灰质炎(VAPP)风险,同时限制疫苗衍生脊髓灰质炎病毒(VDPV)风险;Sabin株衍生IPV是新工具,近期才开始部署,数据正在生成。
要点
- IPV通过循环抗体中和病毒对运动神经元的感染性,对麻痹提供良好保护。
- IPV经黏膜抗体和免疫细胞提供不同程度的黏膜感染保护,程度取决于既往暴露。
- IPV后接OPV序贯程序有潜力消除VAPP风险,同时限制VDPV风险。
核心结论
- IPV将在全球消除脊髓灰质炎中发挥不可替代的作用。
研究设计与样本
- 本文为综述,围绕IPV的历史、免疫原理、现代Salk IPV的应用、IPV后接OPV序贯程序及Sabin株衍生IPV展开论述。
主要发现
- IPV通过循环抗体中和病毒对运动神经元的感染性,实现对麻痹的良好保护。
- IPV经黏膜抗体和免疫细胞提供不同程度的黏膜感染(因而传播)保护,程度取决于受试者既往对野生型或疫苗脊髓灰质炎病毒的暴露。
- IPV后接OPV的序贯免疫程序有潜力消除疫苗相关麻痹性脊髓灰质炎(VAPP)风险,同时限制疫苗衍生脊髓灰质炎病毒(VDPVs)风险。
- Sabin株衍生IPV是近期才开始部署的新工具,数据正在生成以记录其性能。
临床怎么用
- 基于灭活野生型脊髓灰质炎病毒的现代Salk IPV已在许多国家常规使用。
- IPV后接OPV的序贯免疫程序有潜力消除VAPP风险,同时限制VDPV风险。
- Sabin株衍生IPV是近期才开始部署的新工具,数据正在生成以记录其性能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The inactivated poliovirus vaccine (IPV) is a very old tool in the fight against poliomyelitis. Though supplanted by oral poliovirus vaccine (OPV) in the 1960s and 1970s, the IPV has now become an inevitable choice because of the increasingly recognized risks associated with continuous use of OPVs. Following the pioneering work of Jonas Salk, who established key principles for the IPV, considerable experience has accumulated over the years. This work has led to modern Salk IPV-containing vaccines, based on the use of inactivated wildtype polioviruses, which have been deployed for routine use in many countries. Very good protection against paralysis is achieved with IPV through the presence of circulating antibodies able to neutralize virus infectivity toward motor neurons. In addition, with IPV, a variable degree of protection against mucosal infection (and therefore transmission) through mucosal antibodies and immune cells is achieved, depending on previous exposure of subjects to wildtype or vaccine polioviruses. The use of an IPV-followed-by-OPV sequential immunization schedule has the potential advantage of eliminating the vaccine-associated paralytic poliomyelitis (VAPP) risk, while limiting the risks of vaccine-derived poliovirus (VDPVs). Sabin strain-derived IPVs are new tools, only recently beginning to be deployed, and data are being generated to document their performance. IPVs will play an irreplaceable role in global eradication of polio.
引用
- Vidor JD, Jean-Denis S. [Inactivated poliovirus vaccines: an inevitable choice for eliminating poliomyelitis]. Zhonghua Yu Fang Yi Xue Za Zhi. 2016. PMID: 28057103. doi:10.3760/cma.j.issn.0253-9624.2016.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。